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Interleukin-4 (IL-4), a pleiotropic cytokine, stimulates a dose-dependent increase in the number of mouse primordial germ
cells in culture. Results from bromodeoxyuridine incorporation assays suggest that IL-4 acts as a survival factor rather
than as a mitogen for primordial germ cells in this system. Studies on the embryonic expression patterns of IL-4 and its
receptors, using RT±PCR and ELISA, show that IL-4 and its receptors are present at the correct time and place to in¯uence
PGC numbers in vivo. q 1996 Academic Press, Inc.
INTRODUCTION Russell, 1957; McCoshen and McCallion, 1975). In associa-
tion with leukaemia inhibitory factor (LIF) and basic ®bro-
Primordial germ cells (PGCs) are the founder cells of the blast growth factor (bFGF), SCF can stimulate the adoption
germ line. In the mouse, PGCs are ®rst detectable, by virtue of an ES-cell like phenotype by PGCs in culture (Matsui et
of their endogenous alkaline phosphatase activity, in the al., 1992; Resnick et al., 1992). In addition, transforming
posterior region of the primitive streak and base of the allan- growth factor-b (TGF-b) appears to negatively regulate PGC
tois at 7±8 days postcoitum (dpc, Chiquoine, 1954; Gins- numbers (Godin et al., 1991), and tumour necrosis factor-a
burg et al., 1990). Between 8.5 and 12.5 dpc the PGCs mi- (TNF-a) is a mitogen for PGCs (Kawase et al., 1994).
grate towards and colonise the developing gonads (Chi- Here we report the effects of another factor, interleukin-
quoine, 1954; Clark and Eddy, 1975). During this period the 4 (IL-4), on PGC numbers in vitro. We also present novel
PGCs proliferate, increasing in number from approximately expression data for IL-4 and its receptors, supporting a role
150 at 8.5 dpc to approximately 10,000 by 12.5 dpc (Tam for IL-4 in the regulation of PGC numbers during develop-
and Snow, 1981). ment.
Using an in vitro system it was shown that soluble factors IL-4 was ®rst described for its actions on B cells, but it
released by the developing gonads can stimulate an increase also exerts a variety of effects on a range of other cell types;
in PGC numbers (Godin et al., 1990). Several puri®ed the nature of these effects often depends on the particular
growth factors have since been shown to affect PGC num- combination of other cytokines present (see Heyworth et
bers in culture. The ®rst of these was Stem Cell Factor (SCF, al., 1990, for a review). A classi®cation of cytokines into
Godin et al., 1991 Dolci et al., 1991). SCF is the product of subfamilies based on their size, gene organisation, sequence
the murine Steel (Sl) locus and the ligand for the c-kit proto- similarity, and predicted or observed secondary structure
oncogene which is encoded by the W locus (Witte, 1990; has placed IL-4 into a group with IL-3, GMCSF, IL-5, and
Chabot et al., 1988; Geissler et al., 1988). The sterility of IL-13 (Boulay and Paul, 1993).
W and Sl mutant mice indicates an essential role for SCF The effects of IL-4 are mediated by cell surface receptors
in PGC survival and/or proliferation in vivo (Mintz and comprising two subunits, i.e., the IL-4 receptor (IL-4R; Har-
ada et al., 1990; Mosley et al., 1989) and the g subunit of
the IL-2 receptor (IL-2Rg), the latter of which is a functional1 Current address: Developmental Biology Research Centre, Ran-
component of at least four cytokine receptor complexes (IL-dall Institute, King's College London, 26-29 Drury Lane, London,
2, IL-4, IL-7, and IL-13; Kondo et al., 1993; Russell et al.,WC2B 5RL, UK.
1993). The IL-4R subunit is thought to be responsible for2 To whom correspondence should be addressed.
speci®c binding of IL-4, and to be unique to the IL-4 recep-3 Current address: Institute of Human Genetics, University of
tor, whereas the IL-2Rg subunit may increase the strengthMinnesota School of Medicine, Box 206 Mayo, 420 Delaware Street
SW, Minneapolis, MN 55455. of ligand±receptor binding and enable the receptor to trans-
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IL-2Rg; 5*-GCTCTAGGGAAGATCTGAGTACTG and 5*-AAG-duce its signal to the cytoplasm (Nowak, 1993, and see
CTGCGGTACAATTCCAGAGCT, giving an expected productDiscussion). Both subunits are members of the type I cyto-
size of 465 bp for murine TBP. Ampli®cation was performed for 35kine receptor superfamily, a group of transmembrane recep-
cycles of 947C for 45 sec, 607C for 45 sec, 727C for 120 sec, withtors which share conserved cysteine residues, a W-S-X-W-
an elongation step of 7 min at 727C in the ®nal cycle. PCR productsS motif, and ®bronectin type III motifs in their extracellular
were electrophoresed on 1% agarose gels containing ethidium bro-
domains. Although these receptors do not possess intrinsic mide in 11 TBE buffer and subsequently visualised under UV illu-
consensus sequences for tyrosine kinase domains, they are mination.
thought to interact with cytoplasmic tyrosine kinases (Isf- Southern blotting of PCR products onto nitrocellulose and subse-
ort and Ihle, 1990; Wang et al., 1993). At least some of the quent hybridisation were performed according to standard proto-
cols (Sambrook et al., 1989). The probe for murine IL-4 (Clontech)downstream effects of IL-4 are probably mediated by STF-
was a 30-base oligodeoxynucleotide complementary to a regionIL-4, a cytoplasmic factor which becomes phosphorylated
within the expected ampli®cation product. The probe was end-on tyrosine following stimulation of cells by IL-4 and then
labeled with 32P using T4 polynucleotide kinase (BRL). Hybridisingtranslocates to the nucleus where it binds DNA (Schindler
bands were visualised using a Phosphoimager.et al., 1994).
Like SCF, IL-4 is a pleiotropic cytokine whose target cells
include haematopoietic progenitor cells (Heyworth et al., Preparation of Protein Extracts
1990). The effects of IL-4 on cells of the adult lymphohaema-
topoietic systems have been well-documented; however, Decidua were isolated from pregnant females, 1 litter at a time,
and stored in PBS on ice. Embryos/decidua were transferred inunlike SCF, a developmental role for IL-4 has not previously
groups of 5 or 10 into ice-cold PBS containing freshly added proteasebeen postulated.
inhibitors (PBS/PI: aprotinin at 2 mg/ml, leupeptin at 0.5 mM, pep-
statin A at 1 mg/ml, and PMSF at 100 mg/ml). Tissues were dissected
in PBS/PI, transferred through two to three washes of ice-cold PBS/MATERIALS AND METHODS
PI, and collected in Eppendorf tubes on ice in as small a volume
of PBS/PI as possible. When all embryos had been dissected and
Isolation and Culture of PGCs tissues of like kind pooled, the preparations were triturated using
a Gilson pipetman ®tted with a yellow (small) tip (for tissues whichIsolation and culture of PGC-containing tissues was performed
were dif®cult to dissociate a glass homogeniser or a Gilson pi-essentially as described previously (Cooke et al., 1993). Brie¯y,
petman ®tted with a blue (large) tip was used for preliminary disso-the posterior primitive streak and allantois of 8.5-dpc MF1 mouse
ciation). Preparations were spun in a microfuge at 47C for 5 min atembryos (where the day on which a vaginal plug was found was
12,000 rpm and the supernatants were removed and immediatelydesignated 0.5 dpc) were dissected, pooled, and mechanically disso-
frozen on dry ice before transfer to 0807C for longer-term storage.ciated. The resulting cell suspension was diluted in DMEM and
Extracts were thawed on ice immediately before use. Samplesthen plated into microtitre wells containing preformed feeder lay-
collected on separate occasions were pooled, spun in a microfugeers of mitotically inactivated STO embryonic ®broblasts in DMEM
at 47C for 5 min at 12,000 rpm in order to remove debris, and theplus fetal calf serum (FCS, to give a ®nal concentration of 7.5%).
resulting supernatants were applied to the enzyme-linked immuno-Appropriate doses of recombinant murine IL-4 (rmIL-4, AMS Bio-
sorbent assay (ELISA) as detailed below.technology) were applied to cultures after 1±2 hr at 377C. For anti-
body blocking, IL-4 and anti-IL-4 (mouse monoclonal, PharMingen)
were incubated together at 377C for at least 1 hr before addition to
ELISAPGC cultures.
Histochemical staining for alkaline phosphatase, performed as
The protocol used was as recommended by PharMingen fordescribed previously (Cooke et al., 1993), was used to identify
mouse cytokine ELISAs. The anti-IL-4 capture antibody was dilutedPGCs. Bromodeoxyuridine (BrdU) incorporation was assayed using
to 4 mg/ml in coating buffer (0.1 M NaHCO3 , pH 8.2) and addedthe Cell Proliferation Kit (Amersham). The assays were performed
at 50 ml/well to enhanced protein-binding ELISA plates (Corning).according to the manufacturer's guidelines, except that alkaline
Plates were covered and incubated overnight at 47C and thenphosphatase staining was performed prior to BrdU detection.
washed twice with PBS/0.05% Tween 20 (PBT). Wells were blocked
with PBS/3% BSA at 200 ml/well for at least 2 hr at room tempera-
ture and then washed twice with PBT.RT±PCR
Standards were serial dilutions of recombinant mouse IL-4 di-
luted in PBS/PI. BSA was added to standards and samples to a ®nalTotal RNA was extracted from tissues using the acid±guanidi-
nium thiocyanate±phenol±chloroform method (Chomczynski and concentration of 3%, and standards and samples were then added
to the plates at 100 ml/well. Plates were covered and incubatedSacchi, 1987) and reverse-transcribed using superscript RT (Gibco-
BRL) and oligo(dT15) primers. Oligodeoxynucleotide primers for overnight at 47C and then washed four times with PBT.
The biotinylated anti-IL-4 detection antibody was diluted to 4 mg/PCR ampli®cation were either purchased from Clontech (IL-4, IL-
4R) or designed according to recommended criteria and synthesised ml in PBS/3% BSA. Wells were incubated with 100 ml of detection
antibody solution for 45 min at room temperature and then washedon an Applied Biosystems 380B DNA synthesiser (mouse interleu-
kin-2 receptorg subunit, IL-2Rg , and mouse TATA binding protein, six times with PBS/Tween. Extravidin-peroxidase (Sigma, a peroxi-
dase-conjugated streptavidin preparation) was diluted to 1 in 35 inTBP). Sequences of the latter two primer pairs were: 5*-CAGTAC-
CGGAGCAACAGAGAGATCGA and 5*-CTATGCAGGCTG- PBS/3% BSA and added at 100 ml/well. After incubation for 30 min
at room temperature, the wells were washed eight times with PBT.CAAGGAGAACCT, giving an expected product size of 500 bp for
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FIG. 1. Effect of various doses of recombinant murine (rm) IL-4 on the number of PGCs isolated from 8.5-dpc embryos and cultured on
STO feeder cells. Bars represent the mean number of PGCs per well plus standard error for ®ve replicate wells. (a) A 10 ng/ml dose of
rmIL-4 causes a signi®cant increase in the number of 8.5-dpc PGCs in culture after 3 days. (b) The stimulatory effect of rmIL-4 on 8.5-
dpc PGCs can be achieved with doses between 10 and 100 ng/ml. (c) A 1 mg/ml dose of a monoclonal anti-IL-4 antibody blocks the
stimulatory effect of 10 ng/ml rmIL-4 on 8.5-dpc PGCs in culture.
One aliquot of substrate buffer was thawed immediately before tion of the antibody alone to the cultures resulted in PGC
use (substrate buffer: 150 mg ABTS [2,2*-azino-bis(3-ethylbenzthia- numbers not signi®cantly different from numbers in control
zoline-6-sulfonic acid)] in 0.1 M citric acid, pH to 4.35, stored at medium (Fig. 1c), indicating that if any IL-4 is released by0207C). H2O2 was added (10 ml of 30% solution per 11 ml of sub- the STO cells it is not suf®cient to alter PGC numbers.
strate buffer) and vortexed before adding 100 ml/well. The colour BrdU incorporation assays were performed in order to as-
reaction was allowed to develop for 10 ±30 min and then stopped
sess whether IL-4 was acting as a mitogen or as a survivalby adding 100 ml SDS/DMF (200 ml N,N-dimethylformamide plus
factor in this system. Cultures of 8.5-dpc PGCs were estab-220 ml H2O plus 80 g sodium dodecyl sulphate) per well.
lished as before (except that Labtek slides from Nunc wereThe absorbance of each well at 405 nm was read and recorded
used instead of microtitre plates, for improved optical clar-by a Multiskan MCC/340 ELISA plate reader.
ity), labeled with BrdU for 1 or 3 hr after 1 or 3 days in
vitro, and immediately ®xed. Fixed cultures were double
RESULTS
TABLE 1Effects of IL-4 on PGCs in Culture
The Effects of IL-4 on 8.5-dpc PGC Numbers in Culture Are
Cultures of 8.5-dpc PGCs were established on STO ®bro- Statistically Signi®cant
blast feeder layers in the presence of 7.5% FCS and supple-
p value frommented with IL-4 at various concentrations. Each experi-
unpaired tment was performed a number of times with similar results;
Experiment Data sets compared testsrepresentative examples are illustrated in Fig. 1. A 10 ng/
ml dose of IL-4 reproducibly gave rise to a signi®cant in- Fig 1a Control medium, Day 3, vs 10 ng/ml 0.030
crease in the number of 8.5-dpc PGCs in this culture sys- IL-4, Day 3
tem, apparent after 3 days in vitro (Fig. 1a, Table 1). The Fig 1b Control medium, Day, 3 vs 10 ng/ml 0.001
IL-4, Day 3effect of IL-4 on PGCs isolated from 8.5-dpc embryos
Control medium, Day 3, vs 50 ng/ml 0.001showed a dose±response relationship, with concentrations
IL-4, Day 3of IL-4 between 1 and 100 ng/ml stimulating an increase in
Fig 1c Control medium, Day 3, vs 10 ng/ml 0.002PGC numbers with respect to control cultures; no effect
IL-4, Day 3was seen with 0.5 ng/ml IL-4 (Fig. 1b). The increase in PGC
10 ng/ml IL-4, Day 3, vs 10 ng/ml 0.026numbers was a speci®c effect of IL-4, since it could be
IL-4 / 1 mg/ml anti-IL-4, Day 3
blocked by an anti-IL-4 monoclonal antibody (Fig. 1c). Addi-
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FIG. 2. Cultures of 8.5-dpc PGCs on STO feeder cells stained for (a) alkaline phosphatase alone and (b) alkaline phosphatase and BrdU. White
arrow, BrdU-negative PGC; white arrowheads, BrdU-positive PGC; black arrowhead, BrdU-positive, alkaline phosphatase-negative cell.
stained for alkaline phosphatase and for BrdU (Fig. 2). The Expression of IL-4
proportion of BrdU-positive PGCs was assessed. The pooled RT±PCR ampli®cation with primers speci®c for murine
results from six independent experiments demonstrated no IL-4 was performed on RNA isolated from whole embryos
signi®cant difference between the proportion of BrdU-positive and from uterine decidual plus placental tissue at 8.5, 10.5,
PGCs in control cultures and in the presence of 10 ng/ml and 12.5 dpc. Decidual and placental tissues were examined
exogenous IL-4 (Fig. 3), even though total PGC numbers in in order to ascertain whether IL-4 is present in the embry-
these experiments still indicated a signi®cant increase in onic milieu even if not transcribed in the embryo itself.
number in the presence of IL-4 compared to control medium. RNA from adult mouse spleen was used as a positive
The results presented here support a novel role for IL-4, control. Reverse transcriptase-negative controls were in-
i.e., in a developmental context. In order to test the rele- cluded for each RNA to ensure that positive signals did not
vance of the in vitro observations to in vivo events, an arise from genomic DNA contamination of RNA prepara-
analysis of the embryonic expression of IL-4 and its recep- tions. A water-only negative control (water instead of cDNA
tors was undertaken. in the PCR reaction) was also included. As a control for
cDNA quality, parallel ampli®cation reactions were per-
formed with primers speci®c for murine TBP transcripts,
which are ubiquitously expressed. The primer pairs for both
TBP and IL-4 were complementary to sequences in separate
exons, so ampli®cation products arising from genomic
DNA would be distinct from cDNA-derived products.
Electrophoresis of the PCR products was performed after
35 cycles of ampli®cation, and ethidium-stained bands of
the expected size for IL-4 were faint but clearly visible in
lanes corresponding to 10.5- and 12.5-dpc whole embryos
and to 8.5-, 10.5-, and 12.5-dpc decidual plus placental tissue
(Fig. 4, middle panel). The presence and identity of the posi-
tive signals arising from these tissues were con®rmed fol-
lowing Southern hybridisation with an oligonucleotide
probe speci®c for murine IL-4 (Fig. 4, bottom panel).
To examine the localisation of IL-4 protein, a sandwich
ELISA was performed. This technique took advantage of
the availability of two monoclonal antibodies speci®c forFIG. 3. BrdU incorporation assays for 8.5-dpc PGCs cultured on
different epitopes on murine IL-4.STO feeder cells. Bars represent mean proportion of PGCs incorpo-
Crude protein extracts were prepared from dissected em-rating BrdU following a 1- or 3-hr labeling period on Day 1 or
bryonic tissues as described. The samples tested were 8.5-Day 3 of the culture period. Results pooled from six independent
dpc whole embryos, 10.5-dpc yolk sac, 10.5-dpc heart, 10.5-experiments indicate that IL-4 is a survival factor rather than a
mitogen for 8.5-dpc PGCs cultured on STO cells. dpc genital ridge region (GR, urogenital ridges plus dorsal
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relatively little protein overall (0.3 and 0.4 mg per well,
respectively), compared with (for example) the 12.5-dpc
yolk sac extract (6.9 mg per well) which did not give a
positive signal.
Expression of IL-4 receptors was analysed using RT±PCR.
Two known receptor subunits cooperate to form the high-
af®nity IL-4 receptor. These are IL-4R (Mosley et al., 1989;
Harada et al., 1990) and IL-2Rg (Kondo et al., 1993; Nowak,
1993; Russell et al., 1993). Both subunits are members of
the type I cytokine receptor superfamily, and IL-2Rg is
shared with receptors for IL-2, IL-7, and IL-13.
Synthesis of cDNA and PCR ampli®cation for 35 cycles
were performed as for IL-4 ampli®cation, and the same con-
trols were included. Ampli®cation primers were comple-
mentary to sequences from separate exons. Neither set of
primers ampli®ed genomic DNA of the same size as the
expected cDNA ampli®cation product.
Following electrophoresis, ethidium-stained bands of the
expected sizes for both IL-4R and IL-2Rg were seen in lanes
corresponding to cDNA from 8.5-, 10.5-, and 12.5-dpc whole
embryos and 10.5- and 12.5-dpc GR as well as the positive
control adult spleen cDNA (Fig. 6). Diagnostic restriction
digestions with EcoRI, to give bands of 414 / 378 bp for IL-
4R ampli®cation products and with XbaI to give bands of
321 / 179 bp for IL-2Rg ampli®cation products con®rmed
the identity of the products (not shown). Expression of IL-
FIG. 4. PCR products arising from ampli®cation of cDNA with 4R transcripts was also detected in 10.5- and 12.5-dpc yolk
primers speci®c for murine IL-4. The top panel shows ethidium- sacs but not in 10.5- and 12.5-dpc limb buds; IL-2Rg tran-stained products arising from a control ampli®cation using primers
scripts were detected in yolk sacs and limb buds from bothspeci®c for TBP. The middle panel shows ethidium-stained prod-
10.5- and 12.5-dpc embryos (data not shown). STO cellucts arising from ampli®cation with IL-4 primers. The gel in this
cDNA gave rise to a weak ampli®cation product for eachpanel was blotted onto nitrocellulose and hybridised to a 32P-labeled
receptor subunit after 35 cycles of ampli®cation. However,30-nucleotide probe speci®c for murine IL-4. The bottom panel is
a PhosphoImager readout from this blot. 8.5, 10.5 12.5, embryonic it is unlikely that STO cells are responsible for mediating
stages in days postcoitum; E, whole embryo RNA; d/p, uterine the effect exerted by IL-4 on PGCs in culture, since PGC
decidual plus placental tissue. Lanes marked ``/'' represent reverse numbers were similar when cultured on STO cells pre-
transcriptase-positive cDNA reactions, lanes marked ``0'' represent treated with IL-4 (which was then blocked by anti-IL-4 be-
reverse transcriptase-negative control cDNA reactions. Lane fore the PGCs were plated) and on untreated STO cells (data
marked H2O is a negative control for the PCR reactions in which not shown).
water was added to the PCR reaction mix instead of cDNA.
DISCUSSION
aorta plus dorsal gut mesentery), 12.5-dpc yolk sac, 12.5-
dpc liver, 12.5-dpc heart, and 12.5-dpc genital ridge region We have shown that a 10 ng/ml dose of IL-4 stimulates
a statistically signi®cant increase in the number of 8.5-dpc(GR, urogenital ridges). Protein extracts were applied to the
ELISA in parallel with serial dilutions of recombinant mu- PGCs cultured in association with STO feeder cells. Since
BrdU incorporation by PGCs in the presence of exogenousrine IL-4 which were used as standards. Data from one
ELISA are presented in Fig. 5 and Table 2. A standard curve IL-4 was not signi®cantly different from control levels, we
concluded that IL-4 was acting as a survival factor ratherof IL-4 concentration versus OD405 was plotted using linear
regression analysis and IL-4 concentrations of samples were than as a mitogen in our culture system. It has been shown
that PGC death in vitro occurs with many features of pro-deduced from the curve (Fig. 5). Extracts giving a positive
signal were 10.5-dpc GR, 12.5-dpc heart, 12.5-dpc liver, and grammed cell death (apoptosis, Pesce et al., 1993). Since IL-
4 causes an increase in the number of PGCs in culture but12.5-dpc GR (Table 2).
A positive signal did not simply re¯ect a large amount of does not increase their rate of entry into mitosis, we suggest
that the increased number of PGCs seen in culture in theoverall protein, as shown in Table 2. The amount of total
protein per well for each extract was assessed using the presence of IL-4 is a result of the suppression of apoptosis
by this factor.Bradford dye assay. The extracts for 10.5- and 12.5-dpc GR,
which each gave a positive signal in the ELISA, contained In order to reconcile the in vitro data with the in vivo
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the tissues in which the PGC population is present during
these stages. IL-4 protein was not detected in 8.5-dpc em-
bryos but the possibility that IL-4, perhaps synthesised by
uterine decidual cells, is present below the limits of detec-
tion in 8.5-dpc embryos has not been ruled out.
Transcripts for both known IL-4 receptor subunits are
expressed by embryos at 8.5, 10.5, and 12.5 dpc and by GR
tissue from 10.5- and 12.5-dpc embryos. Thus, like IL-4 pro-
tein, IL-4 receptors appear to be present in the vicinity of
the PGC population between 10.5 and 12.5 dpc; the recep-
tors are also present from at least as early as 8.5 dpc.
Whether it is the PGCs themselves which express the recep-
tors or their neighbouring somatic cells remains to be deter-
mined.
The IL-4 and IL-2Rg genes have both been targeted in
mice (Kopf et al., 1993; Kuhn et al., 1991; DiSanto et al.,
1995), but no defect in the germ cell compartment has been
reported for any of these mutants. One explanation for aFIG. 5. ELISA for IL-4 in embryonic tissue protein extracts. Stan-
possible lack of effect on PGCs in IL-4-null mice is thedard curve for one ELISA from which the IL-4 content of samples
transplacental rescue of the phenotype by maternal IL-4.was deduced (see Table 2).
Such a rescue is not unprecedented since TGF-b1-null fe-
tuses are rescued by maternal TGF-b1 which crosses the
placenta from their heterozygous mothers (Letterio et al.,
1994). Although the IL-4R subunit is known to bind IL-4,situation, the expression of IL-4 and IL-4 receptors was ana-
it is currently unclear whether IL-4R can signal in the ab-lysed in embryonic tissues. IL-4 mRNA was detected in
sence of IL-2Rg in vivo (DiSanto et al., 1995). Thus, a lackdecidual/placental tissue from 8.5-, 10.5-, and 12.5-dpc con-
of apparent PGC defects in IL-2Rg-minus mice may re¯ectceptuses. Since maternal TGF-b1 and epidermal growth fac-
a residual level of signaling through the IL-4R subunit alone.tor (EGF) are both transported across the placenta to the
As mentioned in the Introduction, a variety of growthdeveloping embryo (Letterio et al., 1994; Popliker et al.,
factors/cytokines have now been shown to affect PGC num-1987, and see below), there is a precedent for supposing that
bers in culture. It seems unlikely that each of these factorsmaternally synthesised humoral factors may play a role in
is absolutely required for an adequate supply of PGCs duringembryonic development. In addition, IL-4 message was de-
normal embryonic development. Rather, changes in the en-tected within the embryo at 10.5 and 12.5 dpc.
vironment, which may occur when development is per-Protein extracts from 10.5- and 12.5-dpc GR gave positive
turbed, may be responded to more ef®ciently by using asignals in 4 of 4 and 2 of 2 ELISAs, respectively. The speci-
complex combination of positive and negative regulatory®city of the assay system and the consistency of the result
factors to restore the PGC population to its optimum size.add weight to the conclusion that IL-4 protein is present in
genital ridge region tissue between 10.5 and 12.5 dpc, i.e., In this scenario, the absence of one of these factors would
TABLE 2
Summary of Total Amount of Protein per Well and Absorbance Readings Plus Corresponding Amounts of IL-4 per Embryo-Equivalent
for One ELISA
mg total
Sample protein/well OD405 (mean { SEM, n) pg IL-4/well E/well pg IL-4/E
8.5-dpc whole embryo 2.4 0.289 { 0.003, n  3 nd 12 nd
10.5-dpc yolk sac 2.6 0.231 { 0.007, n  3 nd 3 nd
10.5-dpc heart 0.2 0.333 { 0.006, n  3 nd 12 nd
10.5-dpc GR 0.3 0.405 { 0.010, n  2 31 11 3
12.5-dpc yolk sac 6.9 0.342 { 0.003, n  3 nd 4 nd
12.5-dpc heart 1.9 0.437 { 0.002, n  3 39 9 4
12.5-dpc liver 4.8 0.433 { 0.013, n  3 38 6 6
12.5-dpc GR 0.4 0.484 { 0.009, n  3 52 7 7
Note. nd, not detected; E, embryo-equivalent.
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